Colombia's Institutos Nacional de Salud was awarded a medium-term grant to establish a pilot chronic disease study site to generate, collect, and disseminate chronic disease data by using multiple mechanisms.
With the increasing incidence of head and neck cancer, the initial thrust to pilot a disease prevention program stemmed from the South East London Tumour Working Group.
The network structure, and pilot projects on disease prevention and early detection, are in the planning stages.
Descriptive statistics (frequency of endorsement of each response option) were used to examine the patient relevance rankings of the pilot questionnaire by disease status: localized or metastatic.
The high response rate and the practitioners' willingness to participate in a proposed pilot non-communicable disease surveillance system indicate that there is a general interest from the private sector in cooperating.
Although our study was planned as a phase I pilot study, the disease control rate and overall survival rate observed with DCGEM treatment was promising, and we observed fewer adverse effects compared with gemcitabine in combination with S-1 or nab-paclitaxel.
In our previous studies (M.K., unpublished data) of adoptive transfer originating from sentinel nodes, on average, 71 million clonally expanded autologous tumor-reactive lymphocytes were transfused to each patient, and in that pilot study, the disease of all 16 patients responded to therapy.
A mark of the long way that ME studies have to go can be seen in the work of the National ME Observatory, a lottery-funded project of which I am on the steering committee, which has to conduct the kinds of basic social research, such as piloting an ME disease register, that researchers on other illnesses take for granted.
The programme has piloted community-based disease surveillance (CBDS) and completeness of reporting is over 95%.
